Immunotherapy with T11TS / S-LFA-3 specifically induces apoptosis of brain tumor cells by augmenting intracranial immune status

Anticancer Research

Volumn 25, Issue 4, 2005, Pages 2905-2920

  Mukherjee, Joydeep ^a   Ghosh, Anirban ^a   Sarkar, Pallab ^a   Mazumdar, Malabika ^a   Banerjee, Chandra ^a   Chaudhuri, Swapna ^a  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Apoptosis; Brain tumor; Immunotherapy; T11TS S LFA 3

Indexed keywords

BLOOD GROUP ANTIGEN; ETHYLNITROSOUREA; IMMUNOSTIMULATING AGENT; PROPIDIUM IODIDE; PROTEIN T11TS; RECOMBINANT PROTEIN; SLFA 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN TUMOR; CELL CYCLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNE STATUS; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; LYMPHOCYTIC INFILTRATION; MALE; MICROGLIA; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; TUMOR CELL; UPREGULATION;

ANIMALS; ANTIGENS, CD58; BRAIN; BRAIN NEOPLASMS; CD4-CD8 RATIO; CELL CYCLE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FLOW CYTOMETRY; IMMUNOLOGIC FACTORS; IMMUNOTHERAPY; IN SITU NICK-END LABELING; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICROGLIA; RATS; SPLEEN;

EID: 22944474610     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Greene GM, Hitchon PW, Schelper RL, Yuh W and Dyste GN: Diagnostic yield in CT-guided sterotactic biopsy of glioma. J Neurosurg 71: 494-497, 1989.
2. Wekerle HC, Limington H, Lassmann H and Pleyermann R: Cellular immune reactivity within the CNS. Trends Neurosci 9: 271-279, 1986.
3. Hickey WF, Hsu BL and Kimura H: T-lymphocytes entry into the central nervous system. J Neurosci Res 28: 254-262, 1991.
4. Sedgwick JD, Ford AL, Foulcher E and Airriess R: Central nervous system microglial cell activation and proliferation follows direct interactions with tissue infiltrating T-cell blasts. J Immunol 160: 5320-5330, 1998.
5. Dix AR, Brooks WH, Roszman TL and Morford LA: Immune defects observed in patients with primary malignant brain tumors. J Neuroimmunol 100: 216-232, 1999.
6. Gold R, Hartung HP and Lassmann H: T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with immune defense mechanisms. Trends Neurosci 20: 399-404, 1997.
7. Bauer J, Bradl M, Hickley WF, Fross-Petter S, Breitschopf H, Linington C, Wekerie H and Lassmann H: T cell apoptosis in inflammatory brain lesions: destruction of T cell does not depend on antigen recognition. Am J Pathol 153: 715-718, 1998.
8. Savill J, Dransfield I, Gregory C and Haslett C: A blast from the past: clearance of apoptotic cells regulates immune responses. Nature Rev Immunol 2: 965-975, 2002.
9. Becher B, Prat A and Antel JP: Brain immune connection: immuno regulatory properties of CNS- resident cells. Glia 29: 293-304, 2000.
10. Mukherjee J, Dutta S, Sarkar S, Begum Z, Ghosh A, Chaudhuri S and Chaudhuri Swapna: Preclinical changes in immunoreactivity and cellular architecture during the progressive development of intracranial neoplasms and an immuno- therapeutic schedule with a novel biological response modifier, the T11TS / S-LFA-3. Asian Pacific J Cancer Prev 3: 325-337, 2002.
11. Sarkar S, Begum Z, Dutta S, Chaudhuri S and Chaudhuri Swapna: Sheep form of leucocyte function antigen-3 (T11TS) exerts immunostimulatory and antitumor activity against experimental brain tumor: a new approach to biological response modifier therapy. J Clin Expt Can Res 21(1): 95-106, 2002.
12. Mukherjee J, Sarkar S, Ghosh A, Duttagupta AK, Chaudhuri S and Chaudhuri Swapna: Immunotherapeutic effects of T11TS / SLFA-3 against nitrosocompound mediated neural genotoxicity. Tox Lett 150: 239-257, 2004.
13. Sarkar S, Ghosh A, Mukherjee J, Chaudhuri S and Chaudhuri Swapna: CD2-SLFA-3/T11TS interaction facilitates immune activation and glioma regression by T11TS. Cane Biol Ther 3(11): 1121-1128, 2004.
14. Begum Z, Ghosh A Sarkar S, Mukherjee J. Mazumdar M, Sarkar P and Chaudhuri Swapna: Documentation of immune profile of microglia through cell surface marker study in glioma model primed by a novel cell surface glycopeptide T11TS/SLFA-3. Glycoconj J 20: 515-523, 2004.
15. Druckray H, Ivancovic S and Preussman XX: Tetragenic and carcinogenic effects in the offspring after single injection of ethylnitrosourea to pregnant rats. Nature 210: 1378-1379, 1966.
16. Lantos PL: Chemical induction of tumors in nervous system: In: (Thomas GT, ed.) NeuroOncology. Curchill Livingstone, New York, London, pp. 85-107, 1993.
17. Kitao T, Takeshita M and Hattori K: Studies on glycopeptide released by trypsin from sheep erythrocytes. J Immunol 117: 310-312, 1976.
18. Hearn MTW (ed.): HPLC of Proteins, Peptides and Polynucleotides. VCH Publishers Inc., NY, 1991.
19. Lowry OH, Rosebrough NJ, Farr AL and Randell RJ: Protein measurement with the folin-phenol reagent. J Biol Chem 193: 265-275, 1951.
20. Chattopadhyay P, Rathore A, Mathur M, Sarkar C, Mahapatra AK and Sinha S: Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumors. Oncogene 15(7): 871-874, 1997.
21. Westphal M, Giese A, Meissner H and Zirkel D: Culture of cells from human tumors of the nervous system on an extracellular matrix derived from bovine corneal endothelial cells. In: Pollard JW and Walker JM (eds.): Basic Cell Cuture Protocols. Humana Press, Totowa, New Jersey, 2nd Edition, pp. 185-207, 2002.
22. + tumor-infiltrating lymphocytes in the central nervous system in comparison with B7.2 gene therapy. Int J Oncol 20: 807-812, 2002.
23. Fischer H and Reichmann G: Brain dendritic cells and macrophage / microglia in central nervous system inflammation. J Immunol 166: 2717-2726, 2001.
24. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F and Riccardi C: A rapid and simple method for measuring thymocytes apoptosis by propidium iodide staining and flowcytometry. J Immunol Meth 139: 271-279, 1991.
25. Darzynkiewicz Z, Bruno S , Del Bino G , Gorczyca W , Hotz MA, Lassota P and Traganos F: Feature of apoptotic cells measured by flowcytometry. Cytometry 13: 795-808, 1992.
26. Piqueras B, Autran B, Derbe P and Gorochov G: Detection of apoptosis at the single cell level by direct incorporation of fluorescein-dUTP in DNA strand breaks. BioTechniques 20: 634-640, 1996.
27. Gavrieli Y, Sherman Y and Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501, 1992.
28. Berke G: Debate: the mechanism of lymphocyte-mediated killing. Lymphocyte-triggered internal target disintegration. Immunol Today 12: 396-399, 1991.
29. Curnow SJ: The role of apoptosis in antibody-dependent cellular cytotoxicity. Cancer Immunol Immunother 36: 149-154, 1993.
30. Aloisi F: Immune function of microglia. Glia 36: 165-179, 2001.
31. Brooks WH, Markesbery WR, Gupta GD and Rozman TL: Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol 4: 219-224, 1978.
32. Weller M, Malipiero U, Rensing-Ehl A, Barr PJ and Fontana A: Fas/APO-1 gene transfer for human malignant glioma. Cancer Res 55: 2936-2944, 1995.
33. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y and Fontana A: Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 94: 954-964, 1994.
34. Weller M, Weinstock C, Will C and Wagenkneckt B: CD95-dependent T-cell killing by glioma cells expressing CD95 ligand - more on tumor immune escape, the CD95 counterattack, and the immune privilege of the brain. Cell Phys Biochem 7: 282-288, 1997.
35. Saas P, Walker PR, Hahne M, Quiquerez AL, Schnuriger V and Perrin G: Fas ligand expression by astrocytoma in vivo; maintaining immune privilege in the brain? J Clin Invest 99: 1173-1178, 1997.
36. Elgert KD, Alleva DG and Mullins DW: Tumor-induced immune dysfunction: the macrophage connection. J Leukoc Biol 64: 275-290, 1998.
37. Zou J, Morford AL, Chougnet C, Dix AR, Brooks AG, Torres N, Shuman JD, Coligan JE, Brooks WH, Roszmann TL and Shearer GM: Human glioma induced immune suppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers. J Immunol 162: 4882-4892, 1999.
38. Roszmann TL, Brooks WH and Elliot LH: Inhibition of lymphocyte responsiveness by glial tumor cell derived suppressive factors. J Neurosurg 67: 874-879, 1987.
39. Urbani F, Maleci A, LaSala A, Lande R and Ausiello CM: Defective expression of interferon-γ, granulocyte-macrophage-colony-stimulating factor, tumor necrosis factor-α and interleukin-6 in activated peripheral blood lymphocytes from glioma patients. J Interferon Cytokine Res 15: 421-429, 1995.
40. Brooks WH, Latta RB, Mahaley MS, Roszmann TL, Dudka L and Skaggs C: Immunology of primary intracranial tumors. Part V. Correlation of a lymphocytic index and clinical status. J Neurosurg 54: 331-337, 1981.
41. Huettner C, Paulus W and Roggendorf W: Messenger RNA expression of the immunesuppressive cytokine IL-10 in human gliomas. Am J Pathol 146: 317-322, 1995.
42. Sarin A, Williams MS, Alexander-Miller MA, Berzofsky JA, Zacharachuk CM and Henkart PA: Target cell lysis by CTL granule exocytosis is independent of ICE / Ced-3 family proteases. Immunity 6: 209-215, 1997.
43. Heibein JA, Barry M, Matyka B and Bleackley RC: Granzyme-B induced mitochondrial inner membrane potential (Dym) and cytochrome-c are caspase independent. J Immunol 163: 4683-4693, 1999.
44. Alimonti JB, Shi L, Balaji PK and Greenberg AH: Granzyme B induces BID mediated cytochrome c release and mitochondrial permeability transition. J Biol Chem 276: 6974-6982, 2001.
45. Trapani JA and Smyth MJ: Functional significance of the perforin/granzyme cell death pathway. Nature Rev Immunol 2: 735-747, 2002.
46. Rogalinska M: Alterations in cell nuclei during apoptosis. Cell Mol Biol Lett 7: 995-1018, 2002.
47. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, Mcgarry T, Kirchuer M, Koths K, Kwiatkowsi D and Williams L: Caspase-3 generated fragment of gelsolin: effector of morphological changes in apoptosis. Science 278: 294-298, 1997.
48. Siliciano RF, Pratt JC and Schmidt RE: Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature 317: 428-430, 1985.
49. Niiazova OP, Osipova SO, Badalova NS and Dekhkankhodzhaeva NA: Early and late E-rosetting forming neutrophils in persistent lambiasis. Med Parasitol (Mosk) 1: 43-47, 1995.
50. Gutierrez M, Froster FI, Mc Conell SA, Cassidy JP, Pollock JM and Bryson DG: The detection CD4+, CD8+, and WC1+ T lymphocytes, B cells and macrophages in fixed and paraffin embedded brain tissue using a range of antigen recovery and amplification techniques. Vet Immunol Immunopathol 71(3-4): 321-334, 1999.
51. Moingeon P, Chang HC, Wallner BP, Stebbins C, Frey AZ and Reinherz EL: CD2-mediated adhesion facilitates T lymphocyte antigen recognition function. Nature 339: 312-314, 1989.
52. Koyasu S, Lawton T, Novick D et al: Role of interaction of CD2 molecule with lymphocyte function - associated antigen3 in T-cell recognition of normal antigen. Proc Natl Acad Sci USA 87: 2603-2607, 1990.